Back
AN2 Therapeutics 10K Form
Sell
44
ANTX
AN2 Therapeutics
Last Price:
$1.39
Seasonality Move:
-47.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ANTX News And Ratings
See the #1 stock for the next 7 days that we like better than ANTX
ANTX Financial Statistics
Sales & Book Value
| Annual Sales: | $84.9B |
|---|---|
| Cash Flow: | $-12M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.94 |
| Price / Book: | 0.48 |
Profitability
| EPS (TTM): | -2.04000 |
|---|---|
| Net Income (TTM): | $-60.7M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
AN2 Therapeutics Earnings Forecast
Key AN2 Therapeutics Financial Ratios
-
Per Share Earnings over the last 8 years have been positive in 3 years.
AN2 Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ANTX |
| Website: | an2therapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ANTX Technical Analysis vs Fundamental Analysis
Sell
44
AN2 Therapeutics (ANTX)
is a Sell
Is AN2 Therapeutics a Buy or a Sell?
-
AN2 Therapeutics stock is rated a SellThe current AN2 Therapeutics [ANTX] share price is $1.40. The Score for ANTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.